Redx appoints senior AstraZeneca executive as new chief executive
Cancer drug developer Redx has appointed Lisa Anson as its chief executive, the Alderley Park-based business announced today.
She will take up her place on the board on June 1. At that time Iain Ross, currently executive chairman, will revert to being non-executive chairman.
Ms Anson, aged 49, has been president of pharmaceutical giant AstraZeneca UK since 2012 and brings significant leadership experience to the role.
Over a 20 year career with AstraZeneca she has held a variety of senior management roles at AstraZeneca in bo... You can carry on reading TheBusinessDesk.com for free, but you have reached the maximum number of pages an unregistered user can view. To register for an account, click here or login below...
